Navigation Links
Alexandria Real Estate Equities, Inc. Executes 15-Year Lease Extension with NIH for 60,000 RSF of Mission-Critical Space at Alexandria's 9800 Medical Center Drive Campus in Shady Grove Life Sciences Center
Date:10/24/2013

PASADENA, Calif., Oct. 24, 2013 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is pleased to announce a 15-year lease extension with the National Institutes of Health (NIH) for approximately 60,000 RSF at Alexandria's 9800 Medical Center Drive campus in the Shady Grove Life Sciences Center of Rockville, Maryland. In addition to the lease extension, Alexandria announces the delivery of an additional approximately 75,000 RSF, also with a 15-year term, to the NIH at the same location. With a total commitment of approximately 135,000 RSF, the NIH will site mission-critical divisions, including the prestigious National Center for Advancing Translational Sciences (NCATS), at Alexandria's four-building, approximately 282,000 RSF campus. The NIH's compelling need to extend and expand its presence reflects Alexandria's AAA location in Maryland's I-270 Corridor, Class A campus, and longstanding reputation, experience and expertise as the best-in-class provider of high-quality real estate for the government's most important life science initiatives.

The NIH divisions sited at Alexandria's 9800 Medical Center Drive campus include NCATS; the National Heart, Lung and Blood Institute; the National Institute of Child Health and Human Development; and the National Institute of Drug Abuse. NCATS, which was pioneered by NIH Director Francis S. Collins, MD, PhD, and established in December 2011, has received an unprecedented annual funding level – more than $550 million. NCATS will occupy approximately
'/>"/>

SOURCE Alexandria Real Estate Equities, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Alexandrias 499 Illinois Street in Mission Bay, San Francisco, Signs Anchor 97,700 Rentable Square Foot Lease with Leading Mid-Cap Life Science Company
2. Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013
3. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
4. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
5. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
6. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
7. Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider Network
8. Venaxis Executes First Commercial Development Agreement and Receives Purchase Order from EMELCA Bioscience for Initial EU Launch
9. Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
10. Fleur de Lis Hydroponics Releases New Line of Hydroponic Products
11. Governor Tomblin Releases October Edge Business Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... report expects global cell isolation and expansion market to ... carefully analyzed data about the vital drivers, restraints, trends, ... Copy of Report @ http://bit.ly/1yUxy0T , According ... will keep witnessing growth at an impressive CAGR during ... by rapid technological advancements, government funding and investments, and ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
(Date:12/22/2014)... 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, with ... announced positive topline safety and tolerability results ... SYN-004, the Company,s investigational oral beta-lactamase enzyme ... (C. difficile) infection, antibiotic-associated diarrhea and ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... May 7 The Sixth Annual Healthcare Unbound Conference ... (TCBI), will feature the coming together of consumer and ... The Conference will take place at the ... 2009. Attendees will include a diverse representation of ...
... May 7 /PRNewswire-FirstCall/ -- Delcath Systems, Inc., ... technology company testing its proprietary Percutaneous Hepatic Perfusion (PHP(TM)) System ... that Eric D. Whitman, MD, Director of the Atlantic Melanoma ... will present at The 7th World Congress on Melanoma, to ...
... Parma Group has reacquired the,marketing rights to its own ... of the American pharmaceutical company Cornerstone; it will,be setting ... market. This presence in the USA will prepare the ... of respiratory illnesses. , The ...
Cached Biology Technology:Sixth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Chronic Care Management & Wellness Promotion 2Sixth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Chronic Care Management & Wellness Promotion 3Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma 2Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma 3The Chiesi Group Lands in the United States 2The Chiesi Group Lands in the United States 3
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor ... from its licensees for highly accurate, clinically validated biometric ... coming from fitness and health sectors, but first responders/military ... is only as useful as the biometric data it ... in long-term mass consumer adoption of wearable products," said ...
(Date:12/5/2014)... 4, 2014 Increased emphasis on product ... new testing and inspection technologies. The convergence of ... a range of innovative test solutions. This trend ... Y, which is generally more inclined towards communication, ... development strategies of test equipment vendors will cater ...
(Date:11/21/2014)... 2014 According to a new ... (Video, RFID, Access Control, Intrusion Detection, Parking Management, Under ... Component Service Geography - Global Forecasts to 2020", published ... to be around $25 Billion in 2014 and is ... a CAGR of 8.69%. Browse 116 market ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... eggs in the nest of a magpie so that their ... their young are not raised together with other magpies. The ... by their foster parents are much lower, according to research ... Spain. The findings are published in Springer,s journal Behavioral ...
... time, large-scale information on the biochemical makeup of ... These molecules are used in research to help ... Making these data accessible to researchers worldwide increases ... NIH,s National Center for Advancing Translational ...
... Calif. , Dec. 11, 2013  DigitalPersona, Inc., ... today announced that the DigitalPersona ® FingerJet ... certified by the National Institute of Standards and ... program to meet the United States Government,s  Personal ...
Cached Biology News:Magpie parents know a baby cuckoo when they see one 2Gene-silencing data now publicly available to help scientists better understand disease 2Gene-silencing data now publicly available to help scientists better understand disease 3DigitalPersona FingerJet Recognition Engine Top Performer in Recent MINEX Testing 2
Antibodies were affinity purified using epitopes specific to Alpha4 immobilized on solid support....
PlusOne Acrylamide PAGE, 1 kg. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Gel Casting Chemicals....
Donor Horse Serum US Origin...
jub, ajuba homolog (Xenopus laevis)...
Biology Products: